Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial

2014 ◽  
Vol 10 (5) ◽  
pp. 390-396 ◽  
Author(s):  
Marco Armando ◽  
Franco De Crescenzo ◽  
Stefano Vicari ◽  
Maria Cristina Digilio ◽  
Maria Pontillo ◽  
...  
Keyword(s):  
Fatty Acids ◽  
High Risk ◽  
Omega 3 Fatty Acids ◽  
Treatment Trial ◽  
Omega 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Indicated Prevention ◽  
Controlled Treatment ◽  
Long Chain

scholarly journals Effects of exergame training combined with omega-3 fatty acids on the elderly brain: a randomized double-blind placebo-controlled trial

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Alexandra Schättin ◽  
Corinne Baier ◽  
Domenique Mai ◽  
Verena Klamroth-Marganska ◽  
Isabelle Herter-Aeberli ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Controlled Trial ◽  
The Elderly ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

2015 ◽  
Vol 5 (1) ◽  
pp. e495-e495 ◽  
Author(s):  
G P Amminger ◽  
A Mechelli ◽  
S Rice ◽  
S-W Kim ◽  
C M Klier ◽  
...  
Keyword(s):  
Fatty Acids ◽  
High Risk ◽  
Young People ◽  
Treatment Response ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Ultra High Risk ◽  
Long Chain
Sign in / Sign up

Export Citation Format

Share Document